PDT | Jotup

Investor Webinar

Retrieved on:

Sunday, March 24, 2024

PDT, Panel

In North America – Tuesday, 26 March at 4:15 pm PDT / 7:15 pm EDT

Key Points:

In North America – Tuesday, 26 March at 4:15 pm PDT / 7:15 pm EDT
Zoom Webinar - details to be provided upon registration.
To register your interest for the webinar please click through to the link below:
After registering your interest, you will receive a confirmation email with information about joining the webinar.
Participants will be able to submit questions via the Panel throughout the presentation, given this is a pre-recorded webinar we highly encourage attendees to send through questions via email beforehand to [email protected] .

aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update

Retrieved on:

Thursday, March 14, 2024

SAN DIEGO, March 14, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced fourth quarter and full year 2023 results and provided a corporate update.

Key Points:

SAN DIEGO, March 14, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or the “Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform, today announced fourth quarter and full year 2023 results and provided a corporate update.
Based on current enrollment projections, the Company anticipates completing enrollment in the study in the second quarter of 2024.
Interested parties may access the call by registering here in order to obtain a dial in, personalized passcode and webcast information.
Links to a live audio webcast and replay may be accessed on the aTyr website Events page at: http://investors.atyrpharma.com/events-and-webcasts .

Maravai LifeSciences Announces March 2024 Investor Conference Schedule

Retrieved on:

Tuesday, March 12, 2024

PDT, Melamaravakkadu, Webcast, Medtech, SAN, News

SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of March.

Key Points:

SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of March.
On March 19, 2024, at 11:15 a.m. PDT, Trey Martin, Chief Executive Officer will participate in a fireside chat at the KeyBanc Capital Markets Life Sciences and MedTech Investor Forum being held virtually.
A live webcast of the presentation will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under News & Events , Upcoming events .
An archived version of the webcast will also be available on the Maravai website after the event is completed.

“Obey Me! Nightbringer” Is Celebrating Its First Anniversary With up to 200 Free Nightmare Summons and a Host of Spectacular Events.

Retrieved on:

Friday, April 5, 2024

Entertainment, Apps, Applications, Technology, Mobile Entertainment, Software, Internet, Electronic Games, PDT, Quiz, Pop Quiz, Great, WW, Nightmare, PM, Multimedia, IOS, Android, Flour

Nightbringer” is celebrating its first anniversary with up to 200 free Nightmare summons and a host of spectacular events.

Key Points:

Nightbringer” is celebrating its first anniversary with up to 200 free Nightmare summons and a host of spectacular events.
(Graphic: Business Wire)
Happy Devil Day 2024 is the title of the celebratory anniversary event.
Up to 200 free summons!
1 & 2 will both feature a free x10 summon once per day for 10 days, for a total of 200 free summons!

Novocure Announces 20 Presentations On Tumor Treating Fields, Highlighting Preclinical Effects in Pancreatic Cancer and Immune Effects, at American Association for Cancer Research (AACR) Annual Meeting 2024

Retrieved on:

Friday, April 5, 2024

Novocure (NASDAQ: NVCR) today announced 20 presentations on Tumor Treating Fields (TTFields) therapy will be delivered at the American Association for Cancer Research (AACR) Annual Meeting 2024, to be held April 5 to 10 in San Diego.

Key Points:

Novocure (NASDAQ: NVCR) today announced 20 presentations on Tumor Treating Fields (TTFields) therapy will be delivered at the American Association for Cancer Research (AACR) Annual Meeting 2024, to be held April 5 to 10 in San Diego.
Presentations from Novocure-sponsored and partner programs include:
Tumor Treating Fields (TTFields) targeted self assembling nanoparticles for pancreatic cancer treatment: In vitro and in vivo assessment.
Tumor Treating Fields (TTFields) induce an anti-tumor immune response in a pancreatic cancer mouse model.
Tumor Treating Fields (TTFields) show efficacy in Triple-Negative breast cancer (TNBC) cells alone and in combination with PARP inhibitor Talazoparib.

MEDIA ALERT: Envoy Attending and Sponsoring ISC West 2024

Retrieved on:

Thursday, April 4, 2024

Professional Services, Data Management, Business, Security, Technology, Software, PDT, Facial recognition, Expo Hall, ISC, Investment, Booth

Envoy , the only integrated workplace platform that connects people, spaces, and data, will be at ISC West 2024 .

Key Points:

Envoy , the only integrated workplace platform that connects people, spaces, and data, will be at ISC West 2024 .
Providing real-time data on workspace utilization and employee preferences, Envoy prioritizes seamless connectivity, streamlined resource access, and robust security measures.
Leveraging unified occupancy data, Envoy empowers informed decision-making on staffing, resource allocation, and real estate investments.
Booth #1054 , Expo Hall, Venetian Expo, Las Vegas
Join Envoy for a refreshing happy hour at 3377 S Las Vegas Blvd.

Zebra Technologies to Unveil New Generative AI Capabilities at Google Cloud Next

Retrieved on:

Thursday, April 4, 2024

Zebra Technologies Corporation (NASDAQ: ZBRA), a leading digital solution provider enabling businesses to intelligently connect data, assets, and people today announced its collaboration with Google Cloud, Android, and Qualcomm Technologies, Inc. to help enterprises deliver transformative customer experiences along with improved employee productivity and insights powered by generative AI.

Key Points:

Zebra Technologies Corporation (NASDAQ: ZBRA), a leading digital solution provider enabling businesses to intelligently connect data, assets, and people today announced its collaboration with Google Cloud, Android, and Qualcomm Technologies, Inc. to help enterprises deliver transformative customer experiences along with improved employee productivity and insights powered by generative AI.
These new, innovative capabilities will be previewed next week at the 2024 Google Cloud Next in Las Vegas.
“Generative AI is fundamentally changing how many organizations operate and will fuel a new era of how both customers and employees will interact with businesses and brands,” said Rouzbeh Aminpour, Global Retail Solution Engineering Manager, Google Cloud.
“By utilizing Google Cloud’s leading gen AI capabilities, Zebra can help companies across industries empower their employees with better tools and new capabilities, making their work more productive.”
Bianculli will be joined by Aminpour and other leaders from Google Cloud and SAP to discuss how enterprises can reimagine document processing and understanding with generative AI during a breakout session at the Google Cloud Next event on April 11, 10:15-11am PDT.

HCA Healthcare, Inc. to Present at May Healthcare Conferences

Retrieved on:

Wednesday, April 3, 2024

Health, Hospitals, Surgery, Other Health, Managed Care, General Health, PDT, Conference, CDT, HCA, Bank, EDT, HCA Healthcare, Hotel

HCA Healthcare, Inc. (NYSE:HCA), is scheduled to present at the following healthcare conferences:

Key Points:

HCA Healthcare, Inc. (NYSE:HCA), is scheduled to present at the following healthcare conferences:
May 14, 2024 at 10:00 am PDT at the Bank of America Securities Conference at the Encore in Las Vegas, NV.
May 28, 2024 at 3:15 pm CDT at the 2024 Leerink Partners Healthcare Crossroads Conference at the Omni Barton Creek in Austin, TX.
May 30, 2024 at 11:00 am EDT at Bernstein’s 40th Annual Strategic Decisions Conference at the Hilton Midtown in New York, NY.
Dates and times may be subject to change, please check the conference schedule or the Investor Relations section of the Company’s website for the latest information.

Rumble Boxing Joins the Fight with The Michael J. Fox Foundation

Retrieved on:

Wednesday, April 3, 2024

Rumble Boxing , an Xponential Fitness brand, announced today its continued partnership for the second consecutive year with Team Fox, the grassroots fundraising community of The Michael J.

Key Points:

Rumble Boxing , an Xponential Fitness brand, announced today its continued partnership for the second consecutive year with Team Fox, the grassroots fundraising community of The Michael J.
Fox Foundation for Parkinson’s Research (MJFF) to raise funds and garner support for Parkinson’s Awareness Month in April.
To amplify the impact, Rumble Boxing is excited to present a multi-city panel tour with Rumble Boxing Co-Founder, Noah Neiman, alongside MJFF community members affected by Parkinson’s.
With over 80 studios nationwide, Rumble Boxing pairs boxing, HIIT, metabolic conditioning, and strength training group fitness for a full-body workout for all fitness levels.

Identiv Announces Asset Purchase Agreement with Security Solutions Provider Vitaprotech for $145 Million

Retrieved on:

Wednesday, April 3, 2024

Identiv, Inc. (NASDAQ: INVE), a global digital security and identification leader in the Internet of Things (IoT), has entered into a definitive asset purchase agreement to sell its physical security, access card, and identity reader operations and assets to Vitaprotech, a security solutions provider.

Key Points:

Identiv, Inc. (NASDAQ: INVE), a global digital security and identification leader in the Internet of Things (IoT), has entered into a definitive asset purchase agreement to sell its physical security, access card, and identity reader operations and assets to Vitaprotech, a security solutions provider.
Under the terms of the agreement, Identiv will receive a cash payment of $145 million upon closing of the transaction, subject to customary adjustments.
“Our globally recognized security business naturally aligns with Vitaprotech’s strategy and vision for the market, creating a world leader in enterprise security.
Upon closing, certain senior executives will join Vitaprotech, including Identiv CEO Steven Humphreys, at which time incoming President Kirsten Newquist will assume the role of CEO of Identiv.